StevenS.BrooksMDMBA FACC

Cardiology • Baltimore, MD

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology

Principal, Brooks Medtech, LLC

Join to view full profile

Dr. Brooks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Brooks' full profile

Already have an account?

Office
3500 Boston Street
Suite 435
Baltimore, MD 21224
Phone+1 410-534-1161
Is this information wrong?

Education & Training

UPMC Medical EducationFellowship, Cardiovascular Disease, 1999 - 2002
UPMC Medical EducationResidency, Internal Medicine, 1996 - 1999
University of Pittsburgh School of MedicineClass of 1996

Certifications & Licensure

MD State Medical License 2003 - 2024
PA State Medical License 1997 - 2008
SC State Medical License 2003 - 2003

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

1 citations
The Geogenomic Mutational Atlas of Pathogens (GoMAP) web system.
David P. Sargeant, Michael W. Hedden, Sandeep Deverasetty, Christy Strong, Izua J. Alaniz, Alexandria Bartlett, Nicholas R. Brandon, Steven B. Brooks, Frederick A. Bro...> ;Plos One. 2014 Mar 27
1 citations
FDA perspective on the need for revised performance goals for evaluating stenting of femoropopliteal arteries.
Lindsay K. Pack, Donna C. Buckley, Jennifer L. Goode, Steven S. Brooks, Lisa M. Lim> ;Catheterization and Cardiovascular Interventions. 2014 May 1
58 citations
Design considerations for studies of the biomechanical environment of the femoropopliteal arteries.
Farzana Ansari, Lindsay K. Pack, Steven S. Brooks, Tina M. Morrison> ;Journal of Vascular Surgery. 2013 Sep 1
27 citations
FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
Allison Kumar, Steven S. Brooks, Kenneth Cavanaugh, Bram Zuckerman> ;Journal of Vascular Surgery. 2009 Dec 1
28 citations
Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylation.
Hsiao-Huei Chen, Catherine J. Baty, Tomoji Maeda, Steven S. Brooks, Linda C. Baker, Takahisa Ueyama, Erdal Gursoy, Samir Saba, Guy Salama, Barry London, Alexandre F.R....> ;Circulation. 2004 Nov 9
Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase.
Al-Shabrawey, M., El-Remessy, A., Gu, X., Brooks, S.S., Hamed, M.S., Huang, P., Caldwell, R.B.> ;Mol Vis. 2003 Oct 8
38 citations
Chronic exposure to interleukin 1beta induces a delayed and reversible alteration in excitation-contraction coupling of cultured cardiomyocytes.
Alain Combes, Carole S. Frye, Bonnie Lemster, Steven S. Brooks, Simon C. Watkins, Arthur M. Feldman, Charles F. McTiernan> ;Pflugers Archiv. 2002 Sep 13
5 citations
UV light synergistically enhances the cardiotoxic effects of interleukin 1β through peroxynitrite formation
Alain Combes, Charles F. McTiernan, Steven S. Brooks, Arthur M. Feldman> ;Journal of Cardiac Failure. 2001 Jun 1
83 citations
Interleukin-1β Inhibits Phospholamban Gene Expression in Cultured Cardiomyocytes
Charles F. McTiernan, Bonnie Lemster, Carole S. Frye, Steven S. Brooks, Alain Combes, Arthur M. Feldman> ;Circulation Research. 1997 Oct 1
Join now to see all

Authored Content

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017

Press Mentions

Dr. Steven Brooks, Former FDA Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation, Joins NDA PartnersJanuary 5th, 2017

Professional Memberships

American College of Cardiology - ACC
Member